OIG flags organ acquisition reimbursement and documentation risks
Sep 20, 2026 edition · GC-2026-0024 · Published 2026-09-20 · Version 2 · Announced
OIG separates an estimated $380 million organ-counting policy conflict from $154,210 in specifically unsupported reimbursement. The findings call for different policy and documentation responses.
What happened
OIG’s organ-acquisition audit, issued September 1 and posted September 3, reviewed costs for 2017–2022. Of 180 sampled organs reported as Medicare usable, forty-three were not used in Medicare-covered transplants and twelve were never transplanted. Medicare reimbursed $2.8 million for those fifty-five organs. OIG estimated approximately $380 million across the six-year period and identified a conflict between CMS guidance and the statutory limit on reimbursement for organs used in Medicare-covered transplants. That estimate is not an organization-specific liability assessment or a direction to recover the entire estimated amount.
The guidance assumed that an organ furnished to a procurement organization or another transplant center would be used for a Medicare transplant, which did not always happen. Separately, two centers lacked documentation for five reported organs, producing $154,210 in unallowable reimbursement. OIG recommended recovery of that amount and revised organ-counting guidance. CMS concurred with recovery but did not specifically concur or nonconcur with the guidance recommendation. The documentation finding and wider policy conflict should therefore be tracked separately.
Scope and timing
- Authority status
- Announced
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
- Affected functions
- Finance, Clinical Operations, Compliance, Legal
- Responsible owner
- Finance
Why it matters
Traceable organ counts and supporting records matter even while CMS’s broader guidance remains in question. An aggregate estimate should not be treated as a facility’s repayment obligation.
Recommended action
Compare reported organ counts with transplant-use and supporting documentation, retaining an audit trail. Escalate actual discrepancies for reimbursement and legal review, and monitor changes to CMS counting guidance without assuming a blanket recovery policy.
Sources
- Organ acquisition reimbursement auditOfficial · HHS OIG · 2026-09-03 · Source review 2026-09-06
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →